Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide. If diagnosed early, curative treatment options such as surgical resection, loco …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths and
the fifth most common cancer worldwide. Most of these patients are seen with advanced …

Hepatocellular carcinoma (HCC) is the liver's most common primary malignancy, with over
half a million new cases diagnosed each year and being the fourth leading cause of cancer …

Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The
HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis …

Introduction: Current methods for HCC diagnosis have not an optimal diagnostic accuracy.
The detection of more than one biomarker seems to improve their individual performance …

Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide, representing
also the main cause of death among cirrhotic patients. In contrast to most other solid tumors …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer-related deaths worldwide. Although the prognosis of patients with HCC is …

Hepatocellular carcinoma (HCC) is a significant cause of mortality in patients with chronic
liver disease around the world. Development of biomarkers for early HCC detection is a …

Simple Summary Molecular biomarkers play a marginal role in clinical practice for
hepatocellular carcinoma (HCC) diagnosis, surveillance and treatment monitoring …